Show simple item record

dc.contributor.authorPapalexi, M.
dc.contributor.authorBamford, D.
dc.contributor.authorNikitas, A.
dc.contributor.authorBreen, Liz
dc.contributor.authorTipi, N.
dc.date.accessioned2021-12-07T16:10:32Z
dc.date.accessioned2021-12-14T09:12:54Z
dc.date.available2021-12-07T16:10:32Z
dc.date.available2021-12-14T09:12:54Z
dc.date.issued2022-05-06
dc.identifier.citationPapalexi M, Bamford D, Nikitas A et al (2022) Pharmaceutical supply chains and management innovation? Supply Chain Management. 27(4): 485-508.en_US
dc.identifier.urihttp://hdl.handle.net/10454/18679
dc.descriptionYesen_US
dc.description.abstractThis paper aims to evaluate the implementation of innovative programmes within the downstream domain of the pharmaceutical supply chain (PSC), with the aim of informing improved service provision. A mixed-method approach was used to assess to what extent innovation could be adopted by hospital and community pharmacies to improve the delivery process of pharmaceutical products. Unstructured interviews and 130 questionnaires were collected and analysed to identify factors that facilitate or prevent innovation within PSC processes. The analysis led to the creation of the innovative pharmaceutical supply chain framework (IPSCF) that provides guidance to health-care organisations about how supply chain management problems could be addressed by implementing innovative approaches. The results also indicated that the implementation of Lean and Reverse Logistics (RL) practices, supported by integrated information technology systems, can help health-care organisations to enhance their delivery in terms of quality (products and service quality), visibility (knowledge and information sharing), speed (response to customers and suppliers needs) and cost (minimisation of cost and waste). The study’s recommendations have potential implications for supply chain theory and practice, particularly for pharmacies in terms of innovation adoption. The IPSCF provides guidance to pharmacies and health-care organisations to develop more efficient and effective supply chain strategies. This research contributes to the academic literature as it adds novel theoretical insights to highly complex delivery process innovation.en_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttps://doi.org/10.1108/SCM-12-2019-0456en_US
dc.rights(c) 2022 Emerald Publishing Group. This article is distributed under the Creative Commons CC-BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/legalcode)en_US
dc.subjectInnovationen_US
dc.subjectSupply-chain managementen_US
dc.subjectPharmaceuticalsen_US
dc.subjectHealth-care serviceen_US
dc.subjectImprovementen_US
dc.titlePharmaceutical supply chains and management innovation?en_US
dc.status.refereedYesen_US
dc.date.Accepted2021-03-29
dc.date.application2021-08-23
dc.typeArticleen_US
dc.type.versionAccepted manuscripten_US
dc.rights.licenseCC-BY-NC
dc.date.updated2021-12-07T16:10:40Z
refterms.dateFOA2021-12-14T09:14:39Z
dc.openaccess.statusopenAccessen_US


Item file(s)

Thumbnail
Name:
papalexi_et_al_2021.pdf
Size:
907.2Kb
Format:
PDF
Thumbnail
Name:
PharmaceuticalSupplyChainsandM ...
Size:
457.1Kb
Format:
Microsoft Word 2007
Description:
Keep suppressed - Word version

This item appears in the following Collection(s)

Show simple item record